Renalytix plc - Sponsored ADR
RNLXY Healthcare Health Information Services
Renalytix plc - Sponsored ADR’s revenue for fiscal 2025 (year ended June 2025) was $3.0 million, up 30.4% from fiscal 2024. Operating cash flow growth for three consecutive years.
Follow RNLXY
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '24 | Sep '24 | Jun '24 | Mar '24 | Older periods | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
9.69 | 0.91 | 5.40 | 4.70 |
+8 more quarters Free account |
Receivables |
0.51 | 0.90 | 0.70 | 0.55 | |
Inventory |
0.42 | — | 0.30 | — | |
Total current assets |
11.19 | 2.88 | 6.80 | 6.34 | |
Property, Plant, Equpment (Net) |
0.19 | 0.20 | 0.20 | 0.23 | |
Long-Term Investments |
— | 0.78 | 0.70 | 1.06 | |
Long-term assets (Other) |
0.06 | 0.94 | 0.10 | 1.14 | |
Total non-current assets |
0.25 | 1.92 | 0.30 | 2.43 | |
Total Assets |
11.44 | 4.79 | 7.10 | 8.77 | |
Notes Payable |
— | 4.14 | 4.20 | 4.45 | |
Accounts Payable |
4.61 | 5.60 | 7.60 | 5.13 | |
Accrued Expenses |
— | 2.26 | 4.68 | 5.33 | |
Current Part of Capital Lease |
— | 0.01 | 0.05 | 0.08 | |
Total current liabilities |
4.61 | 12.01 | 11.80 | 14.99 | |
Long Term Debt (Total) |
8.21 | 4.10 | 4.30 | 4.89 | |
Total non-current liabilities |
8.21 | 4.10 | 4.30 | 4.89 | |
Total liabilities |
12.81 | 16.11 | 16.10 | 19.88 | |
Additional Paid In Capital |
137.86 | 206.71 | 121.80 | 194.79 | |
Common Stock (Net) |
1.06 | 0.52 | 0.50 | 0.37 | |
Retained Earnings |
(153.26) | (216.51) | (144.70) | (204.71) | |
Shareholders Equity (Other) |
14.78 | — | 14.50 | — | |
Common Equity (Total) |
(1.37) | (11.32) | (9.00) | (11.11) | |
Shareholders Equity (Total) |
(1.37) | (11.32) | (9.00) | (11.11) | |
Shareholders Equity and Liabilities (Total) |
11.44 | 4.79 | 7.10 | 8.77 | |
Shares (Common) |
13.25 | 3.32 | 3.09 | 2.40 | |
Shareholders Equity (Tangible) |
(1.37) | (11.32) | (9.00) | (11.11) | |
Net Debt |
(1.49) | 3.19 | (1.10) | 0.19 | |
Total Debt |
8.21 | 4.10 | 4.30 | 4.89 |